Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease
暂无分享,去创建一个
[1] Jeremy Ferlic,et al. WGCNA : Weighted Gene Co-Expression Network Analysis , 2016 .
[2] D. Zhi,et al. Screening genes crucial for pediatric pilocytic astrocytoma using weighted gene coexpression network analysis combined with methylation data analysis , 2014, Cancer Gene Therapy.
[3] Hai Zhang,et al. GenCLiP 2.0: a web server for functional clustering of genes and construction of molecular networks based on free terms , 2014, Bioinform..
[4] Duan Ma,et al. Integrated microRNA–mRNA analysis of coronary artery disease , 2014, Molecular Biology Reports.
[5] Jonathan E. Clark,et al. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer , 2013, BMC Systems Biology.
[6] Peter McGuffin,et al. Integrative mouse and human mRNA studies using WGCNA nominates novel candidate genes involved in the pathogenesis of major depressive disorder. , 2013, Pharmacogenomics.
[7] J. Hata,et al. Epidemiology of stroke and coronary artery disease in Asia. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[8] John Barnard,et al. Weighted Gene Coexpression Network Analysis of Human Left Atrial Tissue Identifies Gene Modules Associated With Atrial Fibrillation , 2013, Circulation. Cardiovascular genetics.
[9] Tetsuya Ohira,et al. Cardiovascular disease epidemiology in Asia: an overview. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[10] Xia Yang,et al. A Systems Biology Framework Identifies Molecular Underpinnings of Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[11] I. Benjamin,et al. Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease. , 2013, Antioxidants & redox signaling.
[12] F. Recchia,et al. Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. , 2013, American journal of physiology. Heart and circulatory physiology.
[13] T. Vijayakumar,et al. Molecular Studies on Coronary Artery Disease—A Review , 2013, Indian Journal of Clinical Biochemistry.
[14] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[15] Satoshi Okayama,et al. Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography , 2013, Heart and Vessels.
[16] Jennifer G. Robinson,et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis , 2012, The Lancet.
[17] K. Bornfeldt,et al. S100A8 and S100A9 in cardiovascular biology and disease. , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[18] K. Kario,et al. S100A12 as a marker to predict cardiovascular events in patients with chronic coronary artery disease. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[19] Olli Saarela,et al. A Genome-Wide Association Study Identifies LIPA as a Susceptibility Gene for Coronary Artery Disease , 2011, Circulation. Cardiovascular genetics.
[20] Andre R. O. Cavalcanti,et al. Multiple Independent Fusions of Glucose-6-Phosphate Dehydrogenase with Enzymes in the Pentose Phosphate Pathway , 2011, PloS one.
[21] T. Lincoln,et al. Mechanism of glucose-6-phosphate dehydrogenase-mediated regulation of coronary artery contractility. , 2011, American journal of physiology. Heart and circulatory physiology.
[22] H. Bøtker,et al. A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[23] Thomas M. Aune,et al. Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes. , 2011, Genes and immunity.
[24] Weixiong Zhang,et al. A general co-expression network-based approach to gene expression analysis: comparison and applications , 2010, BMC Systems Biology.
[25] Chunquan Li,et al. SubpathwayMiner: a software package for flexible identification of pathways , 2009, Nucleic acids research.
[26] Guoping Fan,et al. Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells , 2009, BMC Genomics.
[27] G. Ertl,et al. Post-infarct remodelling: contribution of wound healing and inflammation , 2008, Cardiovascular research.
[28] David Osumi-Sutherland,et al. FlyBase: enhancing Drosophila Gene Ontology annotations , 2008, Nucleic Acids Res..
[29] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[30] Jun Dong,et al. Geometric Interpretation of Gene Coexpression Network Analysis , 2008, PLoS Comput. Biol..
[31] S. Muntoni,et al. Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease , 2008, Journal of Inherited Metabolic Disease.
[32] David Bryant,et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists , 2007, Nucleic Acids Res..
[33] Kathleen C. Lee,et al. S100A7 (Psoriasin)--mechanism of antibacterial action in wounds. , 2007, The Journal of investigative dermatology.
[34] Dennis B. Troup,et al. NCBI GEO: mining tens of millions of expression profiles—database and tools update , 2006, Nucleic Acids Res..
[35] Andy M. Yip,et al. Gene network interconnectedness and the generalized topological overlap measure , 2007, BMC Bioinformatics.
[36] E. Sarandöl,et al. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. , 2006, Clinical biochemistry.
[37] D. Gutterman,et al. Hypoxia, coronary dilation, and the pentose phosphate pathway. , 2006, American journal of physiology. Heart and circulatory physiology.
[38] J. Loscalzo,et al. Glucose-6 Phosphate Dehydrogenase Deficiency Decreases the Vascular Response to Angiotensin II , 2005, Circulation.
[39] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[40] Z. Ungvari,et al. Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries. , 2003, American journal of physiology. Heart and circulatory physiology.
[41] A. Tajik,et al. Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease , 2003, Circulation.
[42] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[43] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[44] A. Barabasi,et al. Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.
[45] R. Narang,et al. Interrelationship between lipid peroxidation, ascorbic acid and superoxide dismutase in coronary artery disease , 2002 .
[46] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[47] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[48] F. Sebening,et al. [Coronary artery disease]. , 1980, Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung.